Physician profile
Matthew J Austin
NPI 1447463658
$279,049.11
in general payments reported to CMS, 2019-2025
18 companies · $274K in 2025
The $274K reported for 2025 was more than what 99% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $90.18 · 2021: $96.01 · 2022: $1,291 · 2023: $1,127 · 2024: $728 · 2025: $274K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $273K · Food and Beverage: $3,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $273,071.80 |
| Food and Beverage | $3,186.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $273,412.12 | 2019-2025 | Flexband, Ivas, Surpass Evolve |
| Imperative Care, INC | $2,287.30 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom Rdl Radial Access System, 103cm |
| Microvention, INC. | $958.69 | 2019-2025 | Web Aneurysm Embolization System |
| Medtronic USA, INC. | $545.87 | 2019-2020 | |
| Balt USA, LLC | $488.98 | 2020-2023 | |
| Medtronic, INC. | $448.25 | 2021-2025 | Solitaire X, Pipeline, Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $405.89 | 2019-2024 | Penumbra System, Benchmark |
| Neurelis, INC. | $81.53 | 2022 | |
| Angiodynamics, INC. | $68.76 | 2022 | |
| Route 92 Medical, INC. | $56.38 | 2024 | 8f Base Camp Sheath System |
| Depuy Synthes Sales INC. | $55.58 | 2019-2023 | Trufill |
| Ucb, INC. | $52.05 | 2023-2024 | Briviact |
| Boston Scientific Corporation | $51.06 | 2022-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Spyglass Discover |
| Sk Life Science, INC. | $35.43 | 2022-2025 | |
| Phenox INC. | $33.39 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $26.79 | 2019-2023 | Azur Cx Detachable |
| Astrazeneca Pharmaceuticals Lp | $24.46 | 2022 | |
| Abbott Laboratories | $16.58 | 2025 | Xact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.